OpenAlex · Aktualisierung stündlich · Letzte Aktualisierung: 21.03.2026, 05:12

Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.

Current Challenges in the Pharmaceutical Industry and AI's Role in Addressing Them

2025·1 Zitationen
Volltext beim Verlag öffnen

1

Zitationen

7

Autoren

2025

Jahr

Abstract

The pharmaceutical industry is facing a range of challenges, including skyrocketing drug development costs, inefficiencies in clinical trials, supply chain disruptions, stringent quality control standards, and the complex world of marketing and sales. This is where artificial intelligence (AI) steps in, acting as a game-changer by addressing these hurdles with cutting-edge tools like computer-assisted drug design (CADD), predictive modeling, and data analytics. This chapter delves into how AI-driven solutions are boosting the speed, accuracy, and efficiency of pharmaceutical operations, while also recognizing the hurdles posed by inconsistent data, intellectual property issues, and ethical concerns. A thorough look at AI's role in pharmaceutical companies reveals its benefits, drawbacks, and future possibilities, all while stressing the importance of ethical considerations and the need for regulatory flexibility to fully harness AI's groundbreaking potential.

Ähnliche Arbeiten

Autoren

Institutionen

Themen

Computational Drug Discovery MethodsArtificial Intelligence in Healthcare and EducationArtificial Intelligence in Healthcare
Volltext beim Verlag öffnen